CD274 and pancreatic neoplasm: In addition, patients with PD-L1-positive cancer cells were reported to have a significantly poorer prognosis than those with PD-L1-negative cancer cells in pancreatic cancer, urothelial cancer, breast and ovarian cancer patients [16], [18], [21], [28].